Fine Vine: Old Dog,...
Technology: Electronics
Affymetrix Inc. (AFFX: NASDAQ)
$3.69 -0.02 | -0.54%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -10.70M | -28.16M | -10.23M | -23.91M |
| Operating Gains/Losses | 0.00 | 3.06M | -518.00K | 1.11M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -514.00K | 8.26M | 12.60M | -2.21M |
| (Increase) Decrease in Inventories | 12.00K | 6.52M | 5.12M | -3.16M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -21.66M | -448.00K | -12.80M | -5.38M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -3.31M | 160.00K | -2.71M | -2.03M |
| Other Non-Cash Items | 22.05M | 13.52M | 9.49M | -8.13M |
| Net Cash From Continuing Operations | 3.73M | 39.34M | 47.98M | 9.33M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 3.73M | 39.34M | 47.98M | 9.33M |
| Sale of Property, Plant & Equipment | 5.51M | 493.00K | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 385.12M |
| Purchases of Property, Plant & Equipment | -10.53M | -9.03M | -9.11M | -10.75M |
| Acquisitions | -307.80M | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -381.56M |
| Other Cash from Investing Activities | 681.00K | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -258.93M | 127.63M | 66.21M | -7.19M |
| Issuance of Debt | 101.06M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 0.00 | -683.00K | 0.00 | 0.00 |
| Repayment of Long-Term Debt | -22.84M | -3.00K | -143.99M | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | -1.18M | -813.00K |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 276.00K | 200.00K | 416.00K | -49.26M |
| Net Cash From Financing Activities | 78.50M | -486.00K | -144.76M | -50.07M |
| Effect of Exchange Rate Changes | 436.00K | -32.00K | 415.00K | 286.00K |
| Net Change in Cash & Cash Equivalents | -176.27M | 166.45M | -30.16M | -47.65M |
Portfolios with AFFX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserPART 7 JPMorgan 28th Annual...
- UserStockpickrOne
- UserLast Day of the JPMorgan He...
Latest AFFX Headlines from TheStreet
- Affymetrix Inc. Stock Downgraded (AFFX) 04.26.13 | 05:04 am
- Affymetrix Inc. Stock Upgraded (AFFX) 02.04.13 | 04:02 am
- 5 Under-$10 Stocks Primed to Rise in January 01.10.13 | 12:01 pm
- Affymetrix Inc. Stock Downgraded (AFFX) 12.10.12 | 04:12 am
- 4 Stocks Under $10 Making Big Moves 10.19.12 | 02:10 pm
- Stocks Start Week With Stumble 10.08.12 | 05:10 pm
- Affymetrix Inc. Stock Upgraded (AFFX) 08.02.12 | 05:08 am
- Affymetrix Management Discusses Q2 2012 Results - Earnings Call Transcript 07.31.12 | 08:07 pm
- Affymetrix Stock Falls On Unusually High Volume (AFFX) 06.19.12 | 12:06 pm
- Affymetrix's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.03.12 | 10:05 pm
Press Releases for AFFX
- Ingenuity Systems And Affymetrix Partner To Eliminate Microarray Expression Analysis Bottleneck - PR Newswire 04.08.13 | 08:04 am
- Affymetrix Signs Contract With UK Biobank To Genotype 500,000 UK Individuals In The Largest Ever Study Of Genetic And Environmental Factors In Disease And Personalized Medicine - Business Wire 03.22.13 | 09:03 am
- Aqua Gen And Center For Integrative Genomics (CIGENE) Collaborate With Affymetrix On A Salmon Genotyping Array To Achieve The World’s First High-Density View Of The Marker Patterns In The Atlantic Salmon - Business Wire 03.19.13 | 06:03 am
- Affymetrix Names GenoSplice As Its Preferred Data Analysis Service Provider Increasing Accessibility For Bioinformatics In Genomic Research - Business Wire 03.06.13 | 06:03 am
- Affymetrix And DNA Link Sign Partnership For Forensic Test Development For Human Identification - Business Wire 02.07.13 | 06:02 am
- Affymetrix To Webcast Presentation At The 2013 Leerink Swann Global Healthcare Conference - Business Wire 02.05.13 | 04:02 pm
- Affymetrix Reports Fourth Quarter And Fiscal Year 2012 Results - Business Wire 01.31.13 | 04:01 pm
- Affymetrix Announces Preliminary Fourth Quarter Revenue Of $84 Million And Implements Corporate Restructuring To Accelerate Path To Profitability - Business Wire 01.08.13 | 05:01 pm
- Affymetrix To Webcast Presentation At The 31st Annual JP Morgan Healthcare Conference - Business Wire 01.03.13 | 06:01 am
- Affymetrix Announces Redemption Of 3.50% Senior Convertible Notes - Business Wire 12.03.12 | 04:12 pm
Partner Headlines for AFFX
- Luminex Misses Ests., Trims Outlook - Analyst Blog - Zacks 10.30.12 | 10:10 am
- Affymetrix 3Q Guidance Disappoints - Analyst Blog - Zacks 10.13.12 | 07:10 am
- Affymetrix 3Q Guidance Disappoints - Analyst Blog - Zacks 10.12.12 | 06:10 pm
- Morning Market Losers - Benzinga 10.08.12 | 09:10 am
- After Hours Most Active for Oct 3, 2012 : KRFT, SKS, NVDA, OIBR, JPM, BAC, QQQ, PBR/A, PBR, INTC, AMAT, AFFX - NASDAQ 10.03.12 | 08:10 pm
- Luminex Remains Neutral - Analyst Blog - NASDAQ 09.17.12 | 08:09 pm
- Luminex Wins Technology Award - Analyst Blog - NASDAQ 09.07.12 | 04:09 pm
- Affymetrix Reiterated at Neutral - Analyst Blog - NASDAQ 09.07.12 | 03:09 pm
- AFFX Boosts Enterprise Mobility - Analyst Blog - NASDAQ 09.04.12 | 10:09 pm
- Pre-Market Most Active for Aug 30, 2012 : NOK, P, CIEN, FB, BAC, NVS, UN, AFFX, SRPT, ERIC, QQQ, LYB - NASDAQ 08.30.12 | 12:08 pm
